Residency · Rochester, NY
Sponsored by University of Rochester Medicine
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.
The Lancet. Neurology · 2024 · 536 citations · Karl Kieburtz
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
The Lancet. Neurology · 2023 · 586 citations · Karl Kieburtz
Platelet Transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines.
JAMA · 2025 · 85 citations · Moritz Stolla
Mental illness and suicide among physicians.
Lancet (London, England) · 2021 · 210 citations · Ronald Epstein
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
The Lancet. Neurology · 2024 · 126 citations · Karl Kieburtz
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.
The Lancet. Neurology · 2024 · 72 citations · Karl Kieburtz
Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance.
Nature · 2021 · 272 citations · Danielle Vargas
Remote smartphone monitoring of Parkinson's disease and individual response to therapy.
Nature biotechnology · 2022 · 84 citations · Karl Kieburtz